S
SAVARA INC
NASDAQ: SVRA (Savara, Inc.)
Last update: 3 hours ago4.99
0.07 (1.42%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Savara, Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| SVRA | - | - | - | 9.38 |
| TERN | 6 B | - | - | 6.08 |
| TRML | 1 B | - | - | 4.76 |
| EXEL | - | - | - | 9.42 |
| IVVD | - | - | - | 0.930 |
| ARVN | - | - | - | 0.860 |
AIStockmoo Score
| Value 35% | 0.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | 0.0 |
| Timing 35% | 1.8 |
| AI Technical info | NA |
| Technical Oscillators info | 2.0 |
| Technical Moving Averages info | 1.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| News Mood info | NA |
| Environment | ×0.79 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -22.4% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | 4.1 |
| Final Score | 0.50 |
Select this tab to load the latest available analysis.
|
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 5.38% |
| % Held by Institutions | 98.53% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Venrock Adviser, Llc | 30 Jun 2026 | 14,745,943 |
| Woodline Partners Lp | 30 Jun 2026 | 4,245,119 |
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |